Bladder cancer: open trials in Greece

8 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

NCT06919965
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Laiko General Hospital of Athens, Athens · General Hospital of Athens "G. Gennimatas", Athens · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · Sismanogleio General Hospital, Maroussi · General University Hospital Of Patras, Patras · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-11-03
NCT07419295
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · General Oncological Hospital Of Kifissia Agioi Anargyroi, Kifissia · Athens Medical Center S.A., Maroussi · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-11-03
2024-516906-47-00
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
Trial Treatment · Phase 2/3 · Daiichi Sankyo Inc.
General Hospital of Athens - Alexandra, Athens · Saint Savvas Oncology Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · General University Hospital of Larissa, Larissa · Athens Medical Center S.A., Maroussi · General University Hospital Of Patras, Patras · Metropolitan Hospital, Pireas · Athens Medical Center S.A., Thessaloniki · Theageneio Cancer Hospital, Thessaloniki
Registry updated 2026-10-29
NCT07222488
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Athens Medical Center S.A., Thessaloniki
Registry updated 2026-10-29
2025-522963-14-00
A FIH study to investigate the safety and preliminary efficacy of expanded autologous urothelial cells bioprinted during orthotopic neobladder surgery
Trial Treatment · Phase 1 · Phosprint S.A.
Laiko General Hospital of Athens, Athens · General Hospital of Athens "G. Gennimatas", Athens
Registry updated 2026-10-23
NCT06833073
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Henry Dunant Hospital Center, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-10-01
2026-527804-26-00
Extension Study of the U-LaserPrint-1 Clinical Trial
Trial Treatment · Phase 1/2 · Phosprint S.A.
General Hospital of Athens "G. Gennimatas", Athens · Laiko General Hospital of Athens, Athens
Registry updated 2026-09-17
NCT05303532
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
Trial Treatment · Phase 3 · Astrazeneca AB
General Oncological Hospital Of Kifissia Agioi Anargyroi, Kifissia
Registry updated 2026-09-08

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error